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Evaluating Gene Drive Approaches 
for Public Benefit
Michael R. Santos
Abstract Gene drive approaches—those which bias inheritance of a genetic ele-
ment in a population of sexually reproducing organisms—have the potential to pro-
vide important public benefits. The spread of selected genetic elements in wild 
populations of organisms may help address certain challenges, such as transmission 
of vector-borne human and animal diseases and biodiversity loss due to invasive 
animals. Adapting various naturally occurring gene drive mechanisms to these aims 
is a long-standing research area, and recent advances in genetics have made engi-
neering gene drive systems significantly more technically feasible. Gene drive 
approaches would act through changes in natural environments, thus robust meth-
ods to evaluate potential research and use are important.
Despite the fact that gene drive approaches build on existing paradigms, such as 
genetic modification of organisms and conventional biological control, there are 
material challenges to their evaluation. One challenge is the inherent complexity of 
ecosystems, which makes precise prediction of changes to the environment diffi-
cult. For gene drive approaches that are expected to spread spatially and/or persist 
temporally, responding to this difficulty with the typical stepwise increases in the 
scale of studies may not be straightforward after studies begin in the natural envi-
ronment. A related challenge is that study or use of a gene drive approach may have 
implications for communities beyond the location of introduction, depending on the 
spatial spread and persistence of the approach and the population biology of the 
target organism. This poses a particular governance challenge when spread across 
national borders is plausible. Finally, community engagement is an important ele-
ment of responsible research and governance, but effective community engagement 
for gene drive approaches requires addressing complexity and uncertainty and sup-
porting representative participation in decision making.
These challenges are not confronted in a void. Existing frameworks, processes, 
and institutions provide a basis for effective evaluation of gene drive approaches for 
public benefit. Although engineered gene drive approaches are relatively new, the 
necessities of making decisions despite uncertainty and governing actions with 
potential implications for shared environments are well established. There are meth-
odologies to identify potential harms and assess risks when there is limited 
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 experience to draw upon, and these methodologies have been applied in similar 
contexts. There are also laws, policies, treaties, agreements, and institutions in place 
across many jurisdictions that support national and international decision making 
regarding genetically modified organisms and the potential applications of gene 
drive approaches, such as public health and biodiversity conservation. Community 
engagement is an established component of many decision-making processes, and 
related experience and conceptual frameworks can inform engagement by 
researchers.
The existence of frameworks, processes, and institutions provides an important 
foundation for evaluating gene drive approaches, but it is not sufficient by itself. 
They must be rigorously applied, which requires resources for risk assessment, 
research, and community engagement and diligent implementation by governance 
institutions. The continued evolution of the frameworks, processes, and institutions 
is important to adapt to the growing understanding of gene drive approaches. With 
appropriate resources and diligence, it will be possible to responsibly evaluate and 
make decisions on gene drive approaches for public benefit.
Keywords Gene drive · Risk assessment · Governance · Community engagement · 
Biosafety · Public benefit · Decision making · Uncertainty
 Gene Drive Approaches: Potential to Provide Important 
Public Benefits
Gene drive is a phenomenon of biased inheritance in which the prevalence of a 
genetic element is increased, even in the presence of some fitness cost, leading to 
the preferential increase of a specific genotype that may determine a specific pheno-
type from one generation to the next and potentially throughout a population 
(National Academies of Sciences, Engineering, and Medicine (NASEM) 2016). 
Gene drive is a natural phenomenon observed in populations of many different 
organisms; there are multiple natural mechanisms that lead to gene drive, and the 
phenomenon has been described with various names (Burt and Trivers 2006). An 
important property of gene drive is that the genetic element that increases in fre-
quency in the population can decrease individual fitness compared to a context 
without the driving genetic element. Normally a genetic element conveying a fitness 
cost would be selected against over time, because offspring that do not inherit the 
element will outcompete those that do. However, under some circumstances, the 
drive effect can outweigh a fitness cost (e.g., Burt 2003). This property of gene drive 
has long been recognized as potentially enabling applications that spread traits in 
wild populations of organisms, even if the trait does not convey a fitness advantage 
(e.g., Craig et al. 1960; Von Borstel and Buzzati-Traverso 1962; Curtis 1968).
The features of gene drive enable potential applications of gene drive approaches 
for public benefit (e.g., Esvelt et al. 2014; NASEM 2016; Australian Academy of 
M. R. Santos
423
Science 2017). The contexts where gene drive approaches may be most applicable 
are those where the organism of interest reproduces sexually with a short generation 
time (compared to timescales of interest) and there is well-mixed mating across the 
relevant populations (e.g., Burt 2003; Esvelt et  al. 2014). There is long-standing 
interest in gene drive approaches to reducing transmission of vector-borne human 
and animal diseases (e.g., Serebrovsky 1940; Craig et al. 1960; Curtis 1968; Ribeiro 
and Kidwell 1994; Burt 2003, 2014). Given the success of vector control in reduc-
ing the burden of vector-borne diseases (e.g., vector control interventions accounted 
for 78% of the reduction in malaria prevalence from 2000 to 2015; Bhatt et  al. 
2015), complementary gene drive approaches may be transformational tools to 
eliminate or eradicate vector-borne disease (NASEM 2016; NEPAD and the African 
Union 2018). There is also current interest in biodiversity preservation (e.g., through 
population reduction of invasive species or increased resilience for endangered spe-
cies; Redford et al. 2019), agricultural pest control (e.g., Scott et al. 2018), and crop 
resilience (e.g., Pixley et al. 2019). Gene drive approaches can be particularly well 
suited to public benefit because their benefits would accrue to everyone in the 
area of use.
Gene drive approaches may provide a useful complement to other approaches to 
important public goals and should be considered in that context. The potential appli-
cations of gene drive approaches are pursued through a variety of means currently, 
such as insecticides/pesticides/rodenticides, conventional removal of invasive spe-
cies, conventional biocontrol, breeding programs, and genetic modification (e.g., 
NASEM 2016). In many cases existing interventions are insufficient or undesirable 
(e.g., Feachem et al. 2019, for the case of malaria eradication, where cost and wide-
spread insecticide resistance limit the impact of current tools, and Campbell et al. 
2015, for the case of invasive rodents, where cost and toxicity limit the impact of 
toxicants). Gene drive approaches may complement existing interventions by being 
lower cost (because of potential spread and persistence) and species specific in their 
direct effect. As discussed above, gene drive approaches may also promote equity 
because their benefits accrue to the areas in which they are used, rather than to indi-
viduals, and thus do not depend on individual resources such as wealth and time; 
inequity may still exist between areas that have access to gene drive approaches and 
those that do not.
Given the potential for gene drive approaches to provide public benefit, there has 
been research into adapting or recapitulating a variety of natural gene drive mecha-
nisms in organisms of interest, such as disease vectors. This research resulted in 
important advances, such as the first implementation of gene drive in a malaria vec-
tor (Windbichler et al. 2011), and has accelerated dramatically since 2015 due to the 
application of improved genome editing tools, such as CRISPR-Cas-based tools, to 
engineering gene drive (e.g., Dicarlo et al. 2015; Gantz and Bier 2015). There have 
been notable successes in laboratory cage experiments with malaria vectors, dem-
onstrating proof of principle of genes that reduce the population of vectors 
(Hammond et al. 2016) and reduce mosquitoes’ ability to transmit the parasites that 
cause malaria (Gantz et al. 2015). Although resistance to the gene drive mechanism 
may be expected over time (e.g., Burt 2003), different drive mechanisms may be 
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more or less susceptible to the development of resistance, and techniques have been 
identified to delay its development (e.g., Burt 2003; Esvelt et al. 2014; Hammond 
et  al. 2017; Kyrou et  al. 2018; Champer et  al. 2018); in addition, gene drive 
approaches will often not need to operate indefinitely to deliver their public benefit. 
Despite these many technical advances, gene drive is still a difficult phenomenon to 
engineer: highly efficient gene drive has been reported in only a handful of organ-
isms and has been difficult to implement even in well-studied animals like mice 
(e.g., Grunwald et al. 2019; see also Godwin et al. 2019 and Yosef et al. 2019). To 
date, research into genetically engineering gene drive approaches has occurred 
exclusively in laboratory containment, and no genetically engineered gene drives 
have been introduced into the natural environment.
The advances in genome editing tools are generally expected to enable demon-
strations of more varieties of gene drive. Among the principal areas of research are 
efforts to engineer control over the spatial spread and temporal persistence of the 
driving genetic element. Possible approaches include systems where the drive 
mechanism functions only when present above a threshold (e.g., Akbari et al. 2013; 
Oberhofer et al. 2019), which tends to limit the spatial spread of the genetic ele-
ment, and generational limits on the persistence of the gene drive mechanism (e.g., 
Noble et al. 2019), after which natural selection will remove genes with fitness costs 
from the population. Another potential method for limiting spread is using a drive 
mechanism that operates on a specific genetic sequence that is prevalent only in a 
restricted subpopulation (e.g., Sudweeks et al. 2019). In addition to engineering a 
priori control into gene drive approaches, there is active research on methods to stop 
the spread of a driving genetic element (e.g., Esvelt et al. 2014; Vella et al. 2017; 
Basgall et al. 2018; Roggenkamp et al. 2018).
Given the potential for gene drive approaches to contribute to important social 
priorities like human and animal health and biodiversity, and the technical progress 
in engineering them, the potential challenges associated with gene drive approaches 
for public benefit have become a topic of serious consideration for stakeholders (e.g., 
NEPAD and the African Union 2018; Redford et al. 2019). Gene drive approaches 
have similar challenges to other activities that make changes to the natural environ-
ment, such as establishing a nature reserve or building a hydroelectric dam: ecosys-
tems are complex and the consequences of interventions are difficult to predict with 
precision, the environment is spatially interlinked (naturally and through human-
assisted transportation) so some local interventions can have effects beyond the loca-
tion of intervention, and within the affected areas it is not possible for individuals to 
personally opt in or opt out of the effects (e.g., National Research Council 2005).
The following sections discuss the challenges of evaluating gene drive approaches 
for public benefit and methods for addressing them. There is an increasing diversity 
of potential applications and technical strategies for gene drive approaches with a 
wide spectrum of possible properties; thus it is not possible to evaluate them as one 
group (NASEM 2016). The subsequent sections highlight concepts and methods that 
may have applicability in case-by-case evaluation of specific gene drive approaches.
M. R. Santos
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 Challenges of Evaluating Gene Drive Approaches 
for Public Benefit
 Decision-Making Context
The decision-making contexts within which gene drive approaches are evaluated are 
important to understanding the challenges. Because the public benefit use cases 
generally concern impact on communities and the shared environment, there are 
structures already in place for making decisions related to those goals, such as min-
istries of health responsible for infectious disease control and ministries of environ-
ment responsible for endangered species preservation and biodiversity. In addition, 
gene drive approaches, depending on their specifics, may be subject to biosafety 
regulations, policies, and laws, implemented by national biosafety authorities. For 
gene drive approaches where the responsibilities of multiple regulatory and policy 
interests intersect, effective integration can be difficult (e.g., NASEM 2017).
The governance of decisions on gene drive approaches—the decision-making and 
accountability mechanisms—includes laws and treaties as well as “soft law” tools 
such as guidelines, recommendations, and norms (NASEM 2016). Researchers and 
their institutions play a governance role through their own ethical considerations 
(often represented for institutions by institutional review boards or independent eth-
ics committees) and peer- and funder-imposed norms (e.g., Akbari et  al. 2015; 
Emerson et al. 2017). The responsibility to decide on the use of gene drive approaches 
is principally within governments, typically at the national level but potentially also 
at sub-national levels, and among governments through international treaties and 
agreements such as the Cartagena Protocol on Biosafety to the Convention on 
Biological Diversity [CBD] (Secretariat of the CBD 2000). Governance processes at 
all levels are generally organized for case-by-case evaluations.
There is a continuum of decisions required for potential research and use of gene 
drive approaches (NASEM 2016). For research, the common process is that 
researchers propose activities that, where necessary, are externally evaluated. 
Laboratory studies of gene drive approaches within containment are typically sub-
ject to biosafety review (e.g., UC San Diego Institutional Biosafety Program 2018). 
Governance becomes stricter as the likelihood and magnitude of potential undesir-
able outcomes of a decision (“harms”) are judged to increase; for example, the 
Cartagena Protocol on Biosafety includes requirements that apply to the introduc-
tion of living modified organisms into the environment that do not apply to con-
tained use (Secretariat of the CBD 2000; see, e.g., Maiga 2018 for the authorization 
of a field study of a living modified organism without a gene drive approach). 
Decisions regarding use, meaning introduction with direct public benefit as the pri-
mary goal, encompass potentially separate decisions about what uses are permitted 
(regulatory authorization decisions), what uses are actually implemented (policy 
and financing decisions), and what the responsibilities are for harms that are a con-
sequence of use (liability decisions). For example, biosafety regulators and minis-
tries of environment may be responsible for determining under which circumstances, 
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if any, gene drive approaches to reducing malaria transmission are allowed; minis-
tries of health and national malaria control programs may be responsible for decid-
ing if and where gene drive approaches will be funded and delivered; and national 
laws and international treaties may establish liability associated with potential harm 
due to use of the approach (James et al. 2018).
The essential considerations for decision making on gene drive approaches for 
public benefit are evaluations of potential benefits, costs, and harms and their likeli-
hoods (NASEM 2016); these considerations are elements of processes like cost- 
benefit analyses. Benefits, costs, and harms are subjective evaluations that depend 
on values, which differ among individuals and organizations (National Research 
Council 2005). As highlighted above, there may be multiple organizations with 
responsibility for authorization of a specific gene drive approach; these organiza-
tions will have different statutory responsibilities that influence the scope, scale, and 
weights of potential benefits, costs, and harms they consider in their evaluations 
(e.g., NASEM 2017). These evaluations will typically share a common objective: to 
establish potential outcomes associated with proposed research or use of gene drive 
approaches and consider the likelihoods of those outcomes.
 Uncertainty of Potential Benefits, Costs, and Harms
A significant challenge for the evaluation of gene drive approaches is uncertainty in 
the likelihoods of potential benefits, costs, and harms: ecosystems are generally 
complex and there is limited experience with gene drive approaches (NASEM 
2016). The challenge of uncertainty is not specific to gene drive approaches or bio-
technology: large uncertainties are common in the evaluation of many environmen-
tal changes, such as fisheries management (e.g., Schwaab 2014), road construction 
(e.g., Zhao et al. 2004), use of conventional biocontrol organisms (e.g., Benjamin 
and Wesseler 2016), conservation to protect endangered species (e.g., Nicholson 
and Possingham 2007), conventional removal of invasive species (e.g., Kessler 
2011), and reintroduction of extirpated native species (e.g., Carroll et al. 2019). In 
contexts of high uncertainty, particularly regarding potential harms, phased testing 
paradigms use stepwise increases in the scale of studies to balance reduction of 
uncertainty, exposure to potential harms, and speed of evaluation. For example, the 
scale of studies for a gene drive approach might progress successively from physical 
containment to semi-field studies under outdoor confinement, small-scale open field 
studies, and, finally, larger-scale introductions (NASEM 2016). Each step provides 
a higher-fidelity representation of real-world use, thus further reducing uncertainty 
about the expected outcomes of use, but also increases the potential exposure to 
harms. Thus after each step the accumulated evidence informs the decision on 
whether to proceed to the next step; the intensity of governance also typically 
increases through the stepwise process.
There may be limitations to the application of the phased testing paradigm to 
some gene drive approaches. The paradigm is applicable for the earlier phases of 
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research, within physical confinement. However, some gene drive approaches would 
be expected to spatially spread and temporally persist after the first introduction to 
the natural environment, even if that introduction were in the context of a field trial. 
Even when gene drive approaches include mechanisms to control spread and/or per-
sistence, the efficacies of those control mechanisms won’t be known until they are 
tested in the field. For these reasons, field trials of some gene drive approaches may 
be evaluated similarly to decisions about small-scale introductions, where a greater 
degree of environmental exposure is assumed (e.g., James et al. 2018).
The ability to detect incipient harms and respond to, eliminate, or reduce them is 
an important component of the evaluation of potential harms of gene drive 
approaches; this ability is likely to vary substantially across specific cases of gene 
drive approaches (NASEM 2016). In general, the complexity of ecosystems may 
make it difficult to determine whether any changes in the environment that happen 
after the introduction of a gene drive approach were caused by the gene drive 
approach. The potential for some gene drive approaches to spread and persist from 
relatively low prevalence in a population may present an obstacle to circumscribing 
the location where risk response is necessary, even when an effective conventional 
response (e.g., conventional vector control or invasive species removal) is available. 
Gene drive approaches designed to stop the effects of a previously introduced gene 
drive may have particular advantages for removing an undesired gene drive approach 
from the environment (e.g., Vella et al. 2017), but with the associated uncertainty of 
introducing another gene drive approach.
 Potential Spread and Persistence
The potential spatial spread and temporal persistence of some gene drive approaches 
create another important challenge. Depending on the scale of introduction, popula-
tion biology of the target species, and specifics of the approach, communities 
beyond the location of introduction of a gene drive approach may be affected (e.g., 
Marshall 2009). Which communities will be affected, and when, will depend on 
properties of the gene drive approach and natural environment (e.g., North 
et al. 2019).
As a consequence, decision makers such as regulators could be asked to evalu-
ate gene drive approaches expected to spread outside of their jurisdictions, includ-
ing across national borders (e.g., Brown 2017). Policymakers will need to consider 
the legal and political implications of the potential spread of gene drive approaches; 
in particular, the spread of genetically modified organisms across international 
borders is regulated under the Cartagena Protocol on Biosafety (for countries that 
are signatories; Secretariat of the CBD 2000). Legal risks associated with liability 
and redress will be particularly consequential for decisions about potential imple-
mentation of approved gene drive approaches (e.g., Oye et  al. 2014; Glover 
et al. 2018).
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 Community Engagement
Consultation with stakeholders, in particular with communities where research or 
use of gene drive approaches is being considered, is an important element of the 
evaluation of gene drive approaches (e.g., NASEM 2016). For researchers, engage-
ment with affected communities is an ethical obligation (e.g., King et al. 2014). This 
responsibility includes providing transparency into the research being conducted, so 
that concerns can be identified and addressed, and obtaining community acceptance 
of the research (e.g., World Health Organization 2014). In addition, community 
engagement by researchers creates an opportunity for co-development of innova-
tion, where community input is expected to improve the quality of the research (e.g., 
NEPAD and the African Union 2018; Hartley et al. 2019). For other decision mak-
ers, such as regulators, policymakers, and implementers, community engagement is 
commonly an element of their decision-making process (e.g., Quinlan et al. 2016). 
For example, many environmental regulators include opportunity for public com-
ment on their pending decisions, local policymakers often convene meetings of their 
constituents to address questions and concerns, and international governance insti-
tutions like the Convention on Biological Diversity commonly invite online com-
ments on topics under consideration.
There are likely to be multiple elements to the challenge of successful com-
munity engagement in decision making (e.g., Kaebnick et  al. 2014; Quinlan 
et  al. 2016; NASEM 2016). Because of the potential uncertainties in spatial 
spread and temporal persistence of gene drive approaches, it may not be known 
exactly what areas and communities will be affected and when (e.g., Baltzegar 
et  al. 2018). Communicating effectively given the scientific complexity and 
uncertainty of gene drive approaches may also be difficult (e.g., Brossard et al. 
2019). Gene drive approaches will have area-wide effects that, like existing 
community interventions, do not allow for opting in or opting out at the level of 
the individual (e.g., Thizy et al. 2019); elements of research, such as social sci-
ence research or access to private property, may still require individual consent 
(e.g., Kolopack and Lavery 2017). Governments routinely make decisions for 
communities, though the degree and mechanism for representation and partici-
pation vary; for research, community acceptance is less well defined than indi-
vidual consent, and achieving representative perspectives from communities 
can be difficult (e.g., Kaebnick et al. 2014; Thizy et al. 2019). Given that the 
elements of the challenge of community engagement will vary with each indi-
vidual consideration of a gene drive approach, similar to risk assessment there 
is unlikely to be a single prescriptive process appropriate for all gene drive 




Effective evaluation of gene drive approaches for public benefit depends on these 
challenges being successfully addressed. The next section discusses the ground-
work that is already in place and additional efforts required to accomplish this.
 Addressing the Challenges of Evaluating Gene Drive 
Approaches for Public Benefit
The previous section highlighted three important challenges for evaluating gene 
drive approaches for public benefit. The first is that the expected environmental, 
social, and economic effects of the introduction of a gene drive approach will have 
uncertainties, a consequence of the inherent complexity of ecosystems and societies 
and limited experience with gene drive approaches. The second is that research or 
use of a gene drive approach may affect areas beyond the location of introduction, 
including potentially in other countries. The third is that community engagement by 
researchers and other decision makers is important but not straightforward. These 
challenges are common to other decisions about the shared environment, and thus 
there are existing frameworks, processes, and institutions that can help address them.
 Managing Uncertainty in Decision Making
Uncertainty is a common challenge in decision making, and there are frameworks 
to help characterize and reduce uncertainty (e.g., Aven et al. 2014). Risk assess-
ment, a set of methods to identify and analyze potential outcomes of decisions (e.g., 
Rausand 2011), is one of those frameworks and is recognized as important to the 
evaluation of gene drive approaches (e.g., NASEM 2016; Secretariat of the CBD 
2000). Risk assessment is a general and flexible framework that can identify poten-
tial harms and characterize their likelihood. Risk assessment methods can address 
potential health, social, cultural, economic, and environmental harms. The potential 
harms considered in any individual risk assessment will depend on the organization 
performing it. For example, when regulators perform risk assessments, the scope of 
potential harms considered is typically prescribed by laws and policies. Some deci-
sions about gene drive approaches, such as policies about their use, are likely to be 
informed by risk assessments considering different categories of potential harms.
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The first step in risk assessment is identification of potential harms within the 
scope that is being considered. Identifying harms can incorporate analogous prior 
experience (e.g., through checklists of previously experienced harms), and new 
potential harms can be enumerated through systematic processes: situations that 
could conceivably lead to harms are identified (e.g., for gene drive approaches for 
African malaria vectors, Roberts et al. 2017; Teem et al. 2019), and the chain of 
events from the decision to potential harms is articulated. The next step in risk 
assessment is the evaluation of the likelihoods of each potential harm (including 
different types and magnitudes of consequences for a given type of harm); this 
evaluation can be qualitative or quantitative (e.g., Rausand 2011). When there is a 
lack of relevant experience to inform the likelihoods (such as for potential harms 
that have never occurred), the likelihood of a potential harm can be inferred from 
the likelihoods of the events on the causal pathway to that harm: often there are data 
to inform the likelihoods of individual events even when the full pathway is unprec-
edented (e.g., Hayes et al. 2018a). For example, in fault tree analysis the events on 
the causal pathway to a harm are identified along with their logical relationships; 
when the probabilities of the individual events are estimated, they can be combined 
into an estimate of the probability of harm. The estimated likelihoods of harm have 
uncertainties, which can additionally be characterized, including quantitatively 
(e.g., Kaplan and Garrick 1981). Risk assessment conducted in this manner can also 
inform further research on gene drive approaches: by characterizing the expected 
likelihoods of harms and the uncertainties associated with those expectations, 
research studies and monitoring plans can be developed to prioritize reduction of 
the most consequential uncertainties.
Structured risk assessment methods have been applied across a range of complex 
systems, including to living modified organisms (e.g., Hayes et  al. 2018a). Risk 
assessment is a component of many regulatory frameworks, and in particular eco-
logical risk assessment is used by many environmental authorities (e.g., US EPA 
2019; EFSA n.d.) and specifically recommended for the evaluation of gene drive 
approaches (NASEM 2016). The Cartagena Protocol on Biosafety requires “case- by- 
case,” “scientifically sound” risk assessment for international transboundary move-
ment of living modified organisms intended for use in the environment (Secretariat 
of the CBD 2000). No genetically engineered gene drive approach has advanced to 
the stage of risk assessment, but independent probabilistic risk assessments have 
been released for the contained use and small-scale field release of a genetically 
sterile malaria vector in Burkina Faso (Hayes et  al. 2015, 2018b), demonstrating 
methods that could be applied to risk assessments of gene drive approaches.
 Governing Gene Drive Approaches That Could Cross Borders
Similar to gene drive approaches, many environmental decisions have implications 
beyond the area in which they are implemented, and there are frameworks and insti-
tutions to support those decisions. Of particular relevance are decisions in a country 
M. R. Santos
431
that can affect other countries, such as use of water from a shared source (e.g., 
General Assembly of the United Nations 1997). International governance institu-
tions such as regional organizations (e.g., the European Union, the African Union) 
and the United Nations provide platforms for international treaties and agreements, 
which can inform national laws and policies. Specifically, international institutions 
exist to support decision making on living modified organisms (e.g., the Cartagena 
Protocol on Biosafety) and potential applications of gene drive approaches such as 
public health (e.g., the World Health Organization) and biodiversity conservation 
(e.g., the Convention on Biological Diversity). These institutions provide binding 
requirements and guidance to participating countries that apply to gene drive 
approaches, including provisions for liability and redress in cases where a living 
modified organism used within a country moves to another country and causes harm 
(e.g., the Nagoya-Kuala Lumpur Supplementary Protocol; Secretariat of the CBD 
2011). Regional institutions can also provide guidance on the development of 
regional regulatory frameworks and capacity (e.g., in the African Union, Glover 
et al. 2018, and specifically for gene drive approaches for malaria, African Biosafety 
Network of Expertise 2018).
 Effectively Engaging Communities in Decisions
Although community engagement is expected to be challenging for research and 
use of gene drive approaches, there are examples to learn from and frameworks 
to guide future efforts. For example, foundational features of the community 
engagement approach of the Eliminate Dengue/World Mosquito Program have 
been functionally related to their impact, which may be informative for other 
approaches (Kolopack et al. 2015). There are relevant engagement frameworks 
that have been developed for genetically modified mosquitoes (e.g., Lavery et al. 
2010; World Health Organization 2014; Thizy et al. 2019; Singh 2019), mice that 
carry tick- borne pathogens (Buchthal et al. 2019), and biodiversity (e.g., Rask 
and Worthington 2015). The Cartagena Protocol on Biosafety requires its signa-
tories to promote public awareness, understanding, and participation in the deci-
sion-making process for living modified organisms (which many possible gene 
drive approaches would be categorized within), and there is an ongoing program 
of work within the Protocol to advance priority areas (UN Environment 
Programme 2016).
In summary, these frameworks highlight the importance of “an expansive 
notion of ‘engagement’” (Bartumeus et  al. 2019). Identifying communities, 
stakeholders, and publics for engagement, accounting for the uncertainties asso-
ciated with spread and persistence, needs to be continuous because those identi-
fications are likely to evolve (NASEM 2016). Engagement early and throughout 
the research process provides transparency and enables co-creation of approaches 
(e.g., Esvelt 2017; Hartley et  al. 2019). Communication should use language 
appropriate to different audiences so that messages are understandable (e.g., 
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Quinlan et  al. 2016). Finally, a common refrain is the importance of financial 
resources and human capacity dedicated to community engagement, for research 
(e.g., King et  al. 2014) and in government decisions (UN Environment 
Programme 2016).
 Conclusion
Collectively, the existing appropriate frameworks, processes, and institutions pro-
vide a context to address the challenges of evaluating gene drive approaches for public 
benefit. Established methods can characterize the expectations and uncertainties for 
research and use of a gene drive approach, such as the range of areas and communities 
that may be affected. Institutions exist to use that information to make decisions 
given their responsibilities and processes, and national and international governance 
enables decision making across communities beyond those in which a gene drive 
approach is introduced. Community engagement will need to be tailored for each 
individual case, but past experience and conceptual frameworks can guide these 
important activities. The next section closes with important considerations for the 
effective application of this context to evaluate gene drive approaches for public 
benefit.
 Recommendations on Decision Making for Gene 
Drive Approaches
Having identified the context that can help address the challenges to evaluating gene 
drive approaches, the effective  application of that context requires resources to 
implement risk assessment, support research, and engage communities; diligent 
implementation by governance institutions; and the continued evolution of the 
frameworks, processes, and institutions.
Rigorous evaluation of gene drive approaches may be resource intensive, similar 
to other regulatory decisions, and appropriate regulatory capacity is required. Some 
governance institutions may already possess sufficient capacity, and in other cases 
capacity strengthening may be a necessary precursor to evaluation of gene drive 
approaches. International organizations can and should play an important role in 
supporting capacity development (e.g., Glover et al. 2018).
Research is an important tool to inform the potential benefits, costs, harms, and 
likelihoods of different outcomes from the use of a gene drive approach. Baseline 
environmental studies can help characterize population biology and ecosystem rela-
tionships (e.g., Moro et al. 2018) and contained use studies may reduce other uncer-
tainties (e.g., Hayes et al. 2018a). Mathematical modeling can provide insights into 
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potential outcomes of research or use of gene drive approaches over a range of 
potential contexts (e.g., Sánchez et  al. 2019). Ethical, legal, and social science 
research will continue to inform fair and effective approaches for making decisions 
(e.g., National Research Council 2005; NASEM 2016). It is important that these 
research areas receive sufficient funding to provide informative input into the evalu-
ation of gene drive approaches.
Decisions about gene drive approaches for public benefit, like other important pub-
lic decisions, should be made with diligence, rigor, and transparency, with the under-
standing that a just process will produce decisions that are unlikely to satisfy every 
stakeholder. It is a role of governments to fairly represent the values of their constitu-
encies in decision making, recognizing that even in processes widely recognized as 
good governance, such as free and fair elections, a large minority of constituents may 
disagree with the decision (e.g., UN General Assembly 1966). In addition, some gene 
drive approaches may have the potential to spread across national boundaries, requir-
ing national authorities to act on their international obligations.
The frameworks, processes, and institutions that exist to address the challenges 
of evaluating gene drive approaches should continuously improve the support they 
provide for decision making. Given the limited current experience with gene drive 
approaches, it will be valuable to continue to refine the methods for identifying and 
characterizing potential outcomes. Governance at the national level evolves, and 
regular convenings of international institutions provide venues to further interpret 
treaties and agreements and develop guidance. Community engagement methods 
will continue to be informed by experience from research and governance of gene 
drive approaches and analogous domains. Progress in these areas, including on 
international liability and redress, is a necessary complement to technical progress 
on gene drive approaches (e.g., Oye et al. 2014). For example, the Ad Hoc Technical 
Expert Group on Risk Assessment of the Cartagena Protocol on Biosafety is specifi-
cally tasked with informing decisions on whether additional guidance for risk 
assessment of genetically engineered gene drive approaches is necessary (UN 
Environment Programme 2018).
Gene drive approaches have the potential to provide important public benefits by 
making changes in the natural environment. Evaluating them will be challenging for 
decision makers: ecosystems are complex, governing changes that can affect mul-
tiple communities is complicated, and there is limited experience with the use of 
gene drive approaches. However, these challenges are not confronted in a void. 
Because making decisions about the shared environment under conditions of uncer-
tainty is a common responsibility across many domains, there are existing frame-
works, processes, and institutions that can help address these challenges. If the 
appropriate resources and diligence are applied, it will be possible to responsibly 
evaluate and make decisions on gene drive approaches for public benefit.
Acknowledgments I gratefully acknowledge thoughtful input on this contribution from four 
anonymous reviewers, colleagues at the Foundation for the National Institutes of Health, Western 
Michigan University, EHS Consultancy, and the Commonwealth Scientific and Industrial Research 
Organisation.
Evaluating Gene Drive Approaches for Public Benefit
434
References
African Biosafety Network of Expertise (2018) Establishment of the West Africa integrated vector 
management programme. http://nepad-abne.net/establishment-of-the-west-africa-integrated-
vector-management-programme-accra-19-august-2018/
Akbari OS, Matzen KD, Marshall JM et al (2013) A synthetic gene drive system for local, revers-
ible modification and suppression of insect populations. Curr Biol 23(8):671–677
Akbari OS, Bellen HJ, Bier E et al (2015) Safeguarding gene drive experiments in the laboratory. 
Science 349(6251):927–929
Australian Academy of Science (2017) Synthetic gene drives in Australia: implica-
tions of emerging technologies. https://www.science.org.au/support/analysis/reports/
synthetic-gene-drives-australia-implications-emerging-technologies
Aven T, Baraldi P, Flage R, Zio E (2014) Uncertainty in risk assessment: the representation and treat-
ment of uncertainties by probabilistic and non-probabilistic methods. Wiley, Chichester, UK
Baltzegar J, Barnes JC, Elsensohn JE et al (2018) Anticipating complexity in the deployment of 
gene drive insects in agriculture. J Resp Innov 5(sup1):S81–S97
Bartumeus F, Costa GB, Eritja R et al (2019) Sustainable innovation in vector control requires 
strong partnerships with communities. PLOS Negl Trop Dis 13(4):1–5
Basgall EM, Goetting SC, Goeckel ME et al (2018) Gene drive inhibition by the anti-CRISPR 
proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae. Microbiology 164(4):464–474
Benjamin EO, Wesseler JH (2016) A socioeconomic analysis of biocontrol in integrated pest 
management: a review of the effects of uncertainty, irreversibility and flexibility. NJAS  – 
Wageningen J Life Sci 77:53–60
Bhatt S, Weiss DJ, Cameron E et al (2015) The effect of malaria control on Plasmodium falci-
parum in Africa between 2000 and 2015. Nature 526(7572):207–211
Brossard D, Belluck P, Gould F, Wirz CD (2019) Promises and perils of gene drives: navigating 
the communication of complex, post-normal science. Proc Nat Acad Sci 116(16):7692–7697
Brown Z (2017) Economic, regulatory and international implications of gene drives in agriculture. 
Choices 32(2)
Buchthal J, Evans SW, Lunshof J et al (2019) Mice against ticks: an experimental community- 
guided effort to prevent tick-borne disease by altering the shared environment. Phil Trans R 
Soc B 374:20180105
Burt A (2003) Site-specific selfish genes as tools for the control and genetic engineering of natural 
populations. Proc Biolog Sci 270(1518):921–928
Burt A (2014) Heritable strategies for controlling insect vectors of disease. Philo Trans R Soc B 
369:20130432
Burt A, Trivers R (2006) Genes in conflict. Harvard University Press, Cambridge, MA
Campbell K, Beek J, Eason C et al (2015) The next generation of rodent eradications: innovative 
technologies and tools to improve species specificity and increase their feasibility on islands. 
Biolog Conserv 185:47–58
Carroll C, Lacy RC, Fredrickson RJ et al (2019) Biological and sociopolitical sources of uncer-
tainty in population viability analysis for endangered species. Sci Rep 9:10130
Champer J, Liu J, Oh SY et al (2018) Reducing resistance allele formation in CRISPR gene drive. 
PNAS 115(21):5522–5527
Craig G, Hickey W, VendeHey R (1960) An inherited male-producing factor in Aedes aegypti. 
Science 132(3443):1887–1889
Curtis C (1968) Possible use of translocations to fix desirable genes in insect pest populations. 
Nature 218:368–369
Dicarlo JE, Chavez A, Dietz SL et al (2015) Safeguarding CRISPR-Cas9 gene drives in yeast. Nat 
Biotechnol 33:1250–1255




Emerson C, James S, Littler K, Randazzo F (2017) Principles for gene drive research. Science 
358(6367):1135–1136
Esvelt KM (2017) Precaution: open gene drive research. 355(6325):589-590
Esvelt K, Smidler A, Catteruccia F, Church G (2014) Concerning RNA-guided gene drives for the 
alteration of wild populations. eLife 17(3)
Feachem R, Chen I, Akbari O et al (2019) Malaria eradication within a generation: ambitious, 
achievable, and necessary. Lancet 394(10203):1056–1112
Gantz VM, Bier E (2015) The mutagenic chain reaction: a method for converting heterozygous to 
homozygous mutations. Science 348(6233):442–444
Gantz VM, Jasinskiene N, Tatarenkova O et al (2015) Highly efficient Cas9-mediated gene drive 
for population modification of the malaria vector mosquito Anopheles stephensi. PNAS 
112(49):E6736–E6743
General Assembly of the United Nations (1997) Convention on the law of the non-navigational 
uses of international watercourses. United Nations, New York
Glover B, Akinbo O, Savadogo M et al (2018) Strengthening regulatory capacity for gene drives in 
Africa: leveraging NEPAD’s experience in establishing regulatory systems for medicines and 
GM crops in Africa. BMC Proc 12(Suppl 8):11
Godwin J, Serr M, Barnhill-Dilling SK et al (2019) Rodent gene drives for conservation: opportu-
nities and data needs. Proc R Soc B Biol Sci 286(1914):1606
Grunwald HA, Gantz VM, Poplawski G et al (2019) Super-mendelian inheritance mediated by 
CRISPR–Cas9 in the female mouse germline. Nature 566:105–109
Hammond A, Galizi R, Kyrou K et al (2016) A CRISPR-Cas9 gene drive system targeting female 
reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol 34:78–83
Hammond AM, Kyrou K, Bruttini M et al (2017) The creation and selection of mutations resistant 
to a gene drive over multiple generations in the malaria mosquito. PLOS Gene 13(10):e1007039
Hartley S, Thizy D, Ledingham K et al (2019) Knowledge engagement in gene drive research for 
malaria control. PLOS Negl Trop Dis 13(4):e0007233
Hayes KR, Barry S, Beebe N et  al (2015) Risk assessment for controlling mosquito vectors 
with engineered nucleases: sterile male construct. Commonwealth Scientific and Industrial 
Research Organisation, Hobart
Hayes KR, Hosack GR, Dana GV et  al (2018a) Identifying and detecting potentially adverse 
ecological outcomes associated with the release of gene-drive modified organisms. J Respons 
Innov 5(supp1):S139–S158
Hayes K, Hosack G, Ickowicz A et al (2018b) Risk assessment for controlling mosquito vectors 
with engineered nucleases: controlled field release for sterile male construct. Commonwealth 
Scientific and Industrial Research Organisation, Hobart
James S, Collins FH, Welkhoff PA et al (2018) Pathway to deployment of gene drive mosquitoes as 
a potential biocontrol tool for elimination of Malaria in Sub-Saharan Africa: recommendations 
of a scientific working group. Am J Trop Med Hyg 98(6 Suppl):1–49
Kaebnick GE, Gusmano MK, Murray TH (2014) The ethics of synthetic biology: next steps and 
prior questions. Hast Cent Rep 44:S4–S26
Kaplan S, Garrick BJ (1981) On the quantitative definition of risk. Risk Anal 1(1):11–27
Kessler C (2011) Invasive species removal and ecosystem recovery in the Mariana Islands; chal-
lenges and outcomes on Sarigan and Anatahan. In: Veitch CR, Clout MN, Towns DR (eds) 
Island invasives: eradication and management. Proceedings of the international conference 
on Island invasives. IUCN and Centre for Biodiversity and Biosecurity, Gland, Switzerland/
Auckland, pp 320–324
King KF, Kolopack P, Merritt MW, Lavery JV (2014) Community engagement and the human 
infrastructure of global health research. BMC Med Ethic 15(1):84
Kolopack P, Lavery J (2017) Informed consent in field trials of gene-drive mosquitoes. Gates Open 
Res 1:14)
Kolopack PA, Parsons JA, Lavery JV (2015) What makes community engagement effective?: 
Lessons from the eliminate dengue program in Queensland, Australia. PLOS Neg Trop Dis 
9(4):e0003713
Evaluating Gene Drive Approaches for Public Benefit
436
Kyrou K, Hammond AM, Galizi R et  al (2018) A CRISPR–Cas9 gene drive targeting double-
sex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat 
Biotechnol 36:1062–1066
Lavery JV, Tinadana PO, Scott TW et al (2010) Towards a framework for community engagement 
in global health research. Trend Parasitol 26(6):279–283
Maiga A (2018) Arrete No 2018-453/MESRSI/SG/ANB.  Ouagadougou: Ministere de 
l’Enseignement Superieur, de la Recherche Scientifique et de l’Innovation
Marshall JM (2009) The effect of gene drive on containment of transgenic mosquitoes. J Theor 
Biol 258(2):250–265
Moro D, Byrne M, Kennedy M et al (2018) Identifying knowledge gaps for gene drive research to 
control invasive animal species: the next CRISPR step. Glob Ecol Conserv 13:e00363
National Academies of Sciences, Engineering, and Medicine (2016) Gene drives on the Horizon: 
advancing science, navigating uncertainty, and aligning research with public values. The 
National Academies Press, Washington, DC
National Academies of Sciences, Engineering, and Medicine (2017) Preparing for future products 
of biotechnology. The National Academies Press, Washington, DC
National Research Council (2005) Decision making for the environment: social and behavioral 
science research priorities. The National Academies Press, Washington, DC
NEPAD and the African Union (2018) Gene drives for Malaria control and elimination in Africa. 
https://www.nepad.org/publication/gene-drives-malaria-control-and-elimination-africa.
Nicholson E, Possingham HP (2007) Making conservation decisions under uncertainty for the 
persistence of multiple species. Ecolog Appl 17(1):251–265
Noble C, Min J, Olejarz J et al (2019) Daisy-chain gene drives for the alteration of local popula-
tions. PNAS 116(17):8275–8282
North AR, Burt A, Godfray HC (2019) Modelling the potential of genetic control of malaria mos-
quitoes at national scale. BMC Biol 17:26
Oberhofer G, Ivy T, Hay BA (2019) Cleave and Rescue, a novel selfish genetic element and gen-
eral strategy for gene drive. PNAS 116(13):6250–6259
Oye KA, Esvelt K, Appleton E et al (2014) Regulating gene drives. Science 345(6197):626–628
Pixley KV, Falck-Zepeda JB, Giller KE et al (2019) Genome editing, gene drives, and synthetic 
biology: will they contribute to disease-resistant crops, and who will benefit? Annu Rev 
Phytopathol 57(1):165–188
Quinlan MM, Smith J, Layton R et al (2016) Experiences in engaging the public on biotechnology 
advances and regulation. Front Bioeng Biotechnol 4:3
Rask M, Worthington R (2015) Governing biodiversity through democratic deliberation. 
Routledge, Oxon/New York
Rausand M (2011) Risk assessment: theory, methods, and applications. Wiley, Hoboken
Redford K, Brooks T, Macfarlane N (2019) In: Adams J (ed) Genetic frontiers for conservation: an 
assessment of synthetic biology and biodiversity conservation. IUCN, Gland
Ribeiro J, Kidwell M (1994) Transposable elements as population drive mechanisms: specification 
of critical parameter values. J Med Entomol 31(1):10–16
Roberts A, de Andrade PP, Okumu F et al (2017) Results from the workshop “Problem Formulation 
for the Use of Gene Drive in Mosquitoes”. Am J Trop Med Hyg 96(3):530–533
Roggenkamp E, Giersch RM, Schrock MN et al (2018) Tuning CRISPR-Cas9 gene drives in sac-
charomyces cerevisiae. G3 Gene Genom Genet 8(3):999–1018
Sánchez CHM, Wu SL, Bennett JB, Marshall JM (2019) MGDrivE: a modular simulation frame-
work for the spread of gene drives through spatially explicit mosquito populations. Method 
Ecol Evol 00:1–11
Schwaab E (2014) Addressing uncertainty in fisheries science and management. National 
Aquarium. https://www.aqua.org/Conserve/fisheries
Scott M, Gould F, Lorenzen M et  al (2018) Agricultural production: assessment of the poten-




Secretariat of the CBD (2000) Cartagena protocol on biosafety to the convention on biological 
diversity: text and annexes. Secretariat of the Convention on Biological Diversity, Montreal
Secretariat of the CBD (2011) Nagoya  – Kuala Lumpur supplementary protocol on liability 
and redress to the cartagena protocol on biosafety. Secretariat of the Convention Biological 
Diversity, Montreal
Serebrovsky A (1940) On the possibility of a new method for the control of insect pests. Zool 
Zh 19:618
Singh JA (2019) Informed consent and community engagement in open field research: lessons for 
gene drive science. BMC Med Ethic 20:54
Sudweeks J, Hollingsworth B, Blondel DV et al (2019) Locally fixed alleles: a method to localize 
gene drive to island populations. Sci Rep 9(1):15821
Teem JL, Ambali A, Glover B et al (2019) Problem formulation for gene drive mosquitoes designed 
to reduce malaria transmission in Africa: results from four regional consultations 2016–2018. 
Malaria J 18(1):347
Thizy D, Emerson C, Gibbs J et al (2019) Guidance on stakeholder engagement practices to inform 
the development of area-wide vector control methods. PLoS 13(4):1–11
UC San Diego Institutional Biosafety Program (2018) Gene drives. https://blink.ucsd.edu/safety/
research-lab/biosafety/gene-drives.html.
UN Environment Programme (2016) Decision adopted by the parties to the cartagena protocol on 
biosafety, CBD/CP/MOP/DEC/VIII/18. UNEP/CBD, Cancun, Mexico
UN Environment Programme (2018) Decision adopted by the parties to the cartagena protocol on 
biosafety, CBD/CP/MOP/DEC/9/13. UNEP/CBD, Sharm El-Sheikh, Egypt
UN General Assembly (1966) International covenant on civil and political rights. United Nations, 
New York
US EPA (2019) Risk assessment. https://www.epa.gov/risk
Vella MR, Gunning CE, Lloyd AL, Gould F (2017) Evaluating strategies for reversing CRISPR- 
Cas9 gene drives. Sci Rep 7:11038
Von Borstel R, Buzzati-Traverso A (1962) On the role of lethal mutants in the control of popula-
tions. Radioisotopes and radiation in entomology: proceedings of a Symposium, Bombay, 5–9 
December 1960. International Atomic Energy Agency, pp 273–278
Windbichler N, Menichelli M, Papathanos P et al (2011) A synthetic homing endonuclease-based 
gene drive system in the human malaria mosquito. Nature 473(7346):212–215
World Health Organization (2014) Guidance framework for testing of genetically modified mos-
quitoes. WHO/TDR, Geneva
Yosef I, Edry-Botzer L, Globus R et al (2019) A genetic system for biasing the sex ratio in mice. 
EMBO Rep 20(8):e48269
Zhao T, Sundararajan SK, Tseng C-L (2004) Highway development decision-making under uncer-
tainty: a real options approach. J Infra Syst 10(1):23–32
Evaluating Gene Drive Approaches for Public Benefit
